Legal text appendix — Food, Drug & Device

The legal chain that produces PA-3's Food, Drug & Device architecture, organized constitutional → federal → state → local. The federal substantive layer threads through the Federal Food, Drug, and Cosmetic Act of 1938 (FFDCA Chapter IV foods; Chapter V drugs; Chapter VI devices); the Public Health Service Act (PHSA biologics §351); the Food Safety Modernization Act (FSMA); the Dietary Supplement Health and Education Act (DSHEA); FALCPA + FASTER allergen labeling; the Modernization of Cosmetics Regulation Act (MoCRA 2022); the Federal Meat Inspection Act (FMIA), Poultry Products Inspection Act (PPIA), and Egg Products Inspection Act (EPIA); the Family Smoking Prevention and Tobacco Control Act (FSPTCA 2009); the Controlled Substances Act (CSA); the Inflation Reduction Act (IRA) Drug Price Negotiation Program; the One Big Beautiful Bill Act (OBBBA P.L. 119-21) restructuring of the IRA orphan-drug exclusion; and Trump EO 14370 (December 18, 2025) directing cannabis rescheduling. The state layer threads through PA Constitution Article I § 27; PA Food Safety Act and PA Retail Food Facility Safety Act; PA Pharmacy Act; PA Controlled Substance, Drug, Device and Cosmetic Act; PA Clean Indoor Air Act with preemption provisions; PA non-cooperative MPI status. The Philadelphia layer threads through Philadelphia Code Title 6 Chapter 6-300 (Food Establishments) and § 6-301 (USDA jurisdictional carve-out at retail); Title 6 Chapter 6-700 tobacco-retailer density cap with 500-foot school buffer; PDPH Office of Food Protection (OFP) at 1101 Market Street; PDPH Get Healthy Philly + Healthy Corner Store Initiative + Food Bucks; FDA Philadelphia District at Mellon Independence Center (900 US Customhouse, 2nd & Chestnut, Philadelphia 19106); DEA Philadelphia Field Division. For the analytical treatment of how each instrument operates and where its gaps fall, see the seven D4 sub-domain pages.

Constitutional foundation

U.S. Constitution

Article I § 8 — Commerce Clause, Spending Clause, and Taxing Clause (Cornell LII).
Commerce Clause supplies federal authority for FFDCA, FSMA, DSHEA, MoCRA, FMIA, PPIA, EPIA, FSPTCA, CSA — each premised on the regulation of food / drug / cosmetic / tobacco / controlled-substance interstate commerce. Spending Clause is the basis for conditional federal grants to states (SNAP / WIC / NSLP nutrition-assistance flows; Medicare drug pricing under IRA; CDC FoodNet surveillance funding). Taxing Clause grounds the federal tobacco tax architecture and the IRA Drug Price Negotiation Program's enforcement mechanism (excise tax on non-compliant manufacturers).
Cited in: every D4 sub-domain.

Fourteenth Amendment Equal Protection Clause (Cornell LII).
Grounds Title VI applied to federally-funded food and drug programs (SNAP service-equity analysis; FDA enforcement disparate-impact attention; CDC FoodNet disaggregation; Justice40-era disadvantaged-community targeting now thinned per MC-03 in D13 and across D4 SDs).
Cited in: SD1, SD3, SD5, SD7.

Pennsylvania Constitution

PA Constitution Article I § 27 — Environmental Rights Amendment (PA Const. art. I § 27).
Substantive constitutional grounding for environmental and food-supply regulation. Reinvigorated by Robinson Township v. Commonwealth, 83 A.3d 901 (Pa. 2013).
Cited in: SD1 (food-supply environmental); SD2 (slaughter and processing environmental); SD6 (controlled-substance environmental disposal).

Federal statutes — food & cosmetics

Federal Food, Drug, and Cosmetic Act (FFDCA) Chapter IV — Foods (21 U.S.C. §§ 341-350l).
Enacted 1938. Governs adulteration, misbranding, labeling, standards of identity. Foundational; bipartisan amendments since 1938. Statutory stability HIGH. EPA enforcement under FDA's Office of Inspections and Investigations (OII) post-July 1, 2024 HFP reorganization; PA-3 inspections operate through the FDA Philadelphia District at Mellon Independence Center.
Cited in: SD1 Food (principal anchor); SD2 (cross-cutting at retail); SD7 (federal architecture synthesis).

Food Safety Modernization Act (FSMA) (21 U.S.C. § 350g et seq.).
Enacted 2011. Establishes Preventive Controls (21 U.S.C. § 350g), Produce Safety, Foreign Supplier Verification Program (FSVP), intentional-adulteration rules. Statutory stability HIGH; bipartisan implementation through 2022 final rules.
Cited in: SD1 Food.

Dietary Supplement Health and Education Act (DSHEA) (21 U.S.C. § 321(ff), § 343-2, § 350b).
Enacted 1994. Defines supplements; pre-market notification (NDI); adverse-event reporting. Structurally light pre-market regime relative to FFDCA Chapter V drugs.
Cited in: SD1 Food.

FALCPA (2004) + FASTER Act (2021) — major-allergen labeling. Big 9 allergens including sesame (added 2021).
Cited in: SD1 Food.

Modernization of Cosmetics Regulation Act (MoCRA) (21 U.S.C. § 364 et seq.).
Enacted 2022. Requires facility registration; product listing; safety substantiation; adverse-event reporting; recall authority. Phased implementation through 2026-2028. Small-business exemption thresholds (facility-registration + product-listing) at small-business levels — the structural reach to small / Black-owned cosmetics manufacturers serving PA-3 Black women cosmetics consumers remains operationally consequential and verification-pending (F4-T2P2-SD1-MoCRA-1; XC-11 application).
Cited in: SD1 Food.

Food and Nutrition Act of 2008 (SNAP) (7 U.S.C. § 2011 et seq.) · Child Nutrition Act (WIC) (42 U.S.C. § 1786) · Richard B. Russell National School Lunch Act (NSLP) (42 U.S.C. § 1751 et seq.).
Spending Clause nutrition-assistance flows. SNAP FY25 maximum benefit ~$8.05/person/day. OBBBA P.L. 119-21 (July 4, 2025) cut $186 billion from SNAP per MC-08 context. USDA Food and Nutrition Service Mid-Atlantic Regional Office administers; PADHS state administration; April 2025 USDA workforce reductions (11,300+ deferred resignations) per MC-07.
Cited in: SD1 Food; cross-reference D12 SD3 nutrition assistance.

Federal statutes — meat & poultry

Federal Meat Inspection Act (FMIA) (21 U.S.C. § 601 et seq.).
Enacted 1906; major amendments 1967. Mandatory ante-mortem and post-mortem inspection at slaughter. FMIA § 1902 humane slaughter / ritual slaughter exemption at 7 U.S.C. § 1902 grounds slaughter-level halal / kosher framework. Statutory stability HIGH.
Cited in: SD2 Meat & Poultry.

Poultry Products Inspection Act (PPIA) (21 U.S.C. § 451 et seq.).
Enacted 1957. Mandatory inspection of poultry products in interstate commerce. USDA FSIS Pathogen Reduction / HACCP Final Rule (1996; 9 CFR 416 + 417) establishes preventive-controls regulatory framework at slaughter and processing. Salmonella Framework for Raw Poultry Products withdrawn April 25, 2025 (90 FR 17344); December 2025 NRTE breaded stuffed chicken sampling indefinite delay per MC-03.
Cited in: SD2 Meat & Poultry.

Egg Products Inspection Act (EPIA) (21 U.S.C. § 1031 et seq.).
Processed-egg-products inspection. Statutory stability HIGH.
Cited in: SD2 Meat & Poultry.

Federal statutes — drugs & biologics

FFDCA Chapter V — Drugs and Devices (21 U.S.C. §§ 351-360fff).
Governs drug approval (NDA/ANDA), post-market surveillance, device approval (PMA/510(k)/De Novo), Risk Evaluation and Mitigation Strategies (REMS). Statutory stability HIGH. April 2025 FDA RIF reduced CDER (~1,000 employees lost over three months) and CDRH (~260 fired, including 40 from Digital Health Center of Excellence) per MC-07.
Cited in: SD3 Drugs; SD4 Biologics & Devices.

Public Health Service Act (PHSA) § 351 (42 U.S.C. § 262).
Biological products licensure (BLA) under CBER. CBER Director Peter Marks departed in April 2025 RIF per MC-07; Acting Director Julie Tierney + Associate Director for Policy James Myers + Director of Regulatory Operations Chris Joneckis subsequently terminated. Casgevy + Lyfgenia (sickle cell disease cell and gene therapies) approved December 8, 2023; ~164 cumulative US uptake through 2025 per MC-05 confirms Philadelphia paradox structural barriers documented at the national level.
Cited in: SD4 Biologics & Devices.

Biologics Price Competition and Innovation Act (BPCIA) (42 U.S.C. § 262(k)).
Enacted 2010. Establishes 351(k) biosimilar pathway with 12-year exclusivity.
Cited in: SD4 Biologics & Devices.

Inflation Reduction Act (IRA) — Medicare Drug Price Negotiation Program (42 U.S.C. § 1320f et seq.).
Enacted 2022. First-round Maximum Fair Prices effective January 1, 2026 (10 drugs; 38-79% off list); Round 2 MFPs announced November 25, 2025 (15 drugs; 38-84%; effective January 1, 2027); estimated $12B annual Part D savings + $685M OOP savings per MC-04. OBBBA P.L. 119-21 (July 4, 2025) broadened orphan-drug exclusion under IRA — drugs designated for multiple rare diseases now excluded (affects drugs like Keytruda); CBO estimates +$8.8B Medicare spending = ~10% reduction in IRA program savings.
Cited in: SD3 Drugs; cross-reference D21 SD3 ACA Marketplace and Commercial Insurance Delivery.

GENEROUS Model (CMS Innovation Center, voluntary Medicaid 5-year MFN-pricing model). Launched January 1, 2026; through December 31, 2030; references UK / France / Germany / Italy / Canada / Japan / Denmark / Switzerland pricing.
Cited in: SD3 Drugs.

Federal statutes — tobacco

Family Smoking Prevention and Tobacco Control Act (FSPTCA) (21 U.S.C. § 387 et seq.).
Enacted 2009. Establishes FDA Center for Tobacco Products (CTP) authority over manufacture, distribution, and marketing of tobacco products. Pre-market review (PMTA, SE) required. Menthol cigarette ban (RIN 0910-AI60) withdrawn January 21, 2025; characterizing-flavors-in-cigars rule (RIN 0910-AI28) withdrawn same day per MC-06. AATCLC v. HHS pending in N.D. Cal. (February 4, 2025 status conference). April 2025 CTP Office of Regulations RIF described as "the entire office responsible for drafting new tobacco regulations" per MC-07; CTP Director Brian King removed April 1, 2025; Bret Koplow appointed Acting Director; CTP RIF subject to Rhode Island injunction per Venable LLP. Menthol = 35% of US cigarette sales; ~85% of Black smokers use menthol.
Cited in: SD5 Tobacco.

Federal statutes — controlled substances

Controlled Substances Act (CSA) (21 U.S.C. § 801 et seq.).
Enacted 1970. Five-schedule classification of controlled substances; DEA registration and quota architecture; Prescription Drug Monitoring Programs (PDMP) state-level architecture under federal funding (CDC + DEA). Statutory stability HIGH.
Cited in: SD6 Controlled Substances.

Mainstreaming Addiction Treatment (MAT) Act of 2022 (21 U.S.C. § 823(g) repeal).
Enacted as part of Consolidated Appropriations Act 2023. Repealed the federal "X-waiver" requirement for buprenorphine prescribing; all DEA-registered practitioners with Schedule III prescribing authority can prescribe buprenorphine for OUD without additional waiver.
Cited in: SD6 Controlled Substances.

Trump Executive Order 14370 — Increasing Medical Marijuana and Cannabidiol Research (signed December 18, 2025).
Directed federal cannabis rescheduling action. DEA Final Order effective April 28, 2026 (Federal Register publication; FR Doc. 2026-08176; Vol. 91 No. 81) placing FDA-approved + state-licensed medical marijuana on Schedule III per MC-01. DEA Medical Marijuana Dispensary Registration Portal opens April 29, 2026 at 9:00 AM EST ($794 annual application fee; 60-day priority window through ~June 27, 2026). Adult-use cannabis remains Schedule I; only FDA-approved products + state-licensed medical cannabis rescheduled; synthetically derived THC (delta-10) excluded. New DEA hearing on broader rescheduling: June 29 - July 15, 2026. Section 280E deduction disallowance lifted for state-licensed medical cannabis effective immediately.
Cited in: SD6 Controlled Substances.

Pennsylvania statutes

PA Food Safety Act / Pennsylvania Food Code (3 P.S. § 5701 et seq.).
State-level food-code adoption; coordination with PADA at retail. PA Department of Agriculture (PADA) Bureau of Food Safety and Laboratory Services regional office Lancaster.
Cited in: SD1 Food; SD2 Meat & Poultry.

PA Retail Food Facility Safety Act (3 P.S. § 5721 et seq.).
Retail-level enforcement.
Cited in: SD2 Meat & Poultry.

PA non-cooperative MPI status.
Pennsylvania elects not to operate a state Meat and Poultry Inspection program; federal-direct USDA-FSIS inspection covers all PA-3-relevant federally-inspected establishments. Structural state-level decision concentrates federal-FSIS demand on Philadelphia District 60 at the moment of federal capacity erosion per MC-07.
Cited in: SD2 Meat & Poultry; G1-SD2-02.

PA Pharmacy Act (63 P.S. § 390-1 et seq.).
Governs pharmacy practice licensure and operations in Pennsylvania. PA Act 77 of 2024 — pharmacy benefit manager (PBM) reform — operative in 2025-2026 with PA-3 independent-pharmacy implications post-Rite-Aid bankruptcy.
Cited in: SD3 Drugs.

PA Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. § 780-101 et seq.).
State-level controlled-substance scheduling and enforcement. PA Department of Drug and Alcohol Programs (DDAP); PA Prescription Drug Monitoring Program (PA PDMP) administered by PA Department of Health.
Cited in: SD6 Controlled Substances.

PA Clean Indoor Air Act of 2008 (35 P.S. § 637.1 et seq.).
Smoke-free workplace requirements. Preemption provisions limit local tobacco regulation beyond the state floor; Philadelphia retains Home Rule authority for tobacco-retailer licensing density (Title 6 Chapter 6-700) but is preempted on additional smoke-free expansions.
Cited in: SD5 Tobacco; D4-Thread B (state preemption of local product regulation).

Philadelphia ordinances

Philadelphia Code Title 6 Chapter 6-300 (Food Establishments) (Phila. Code Title 6).
Retail food licensing; food handler certification; inspection regime. Home Rule basis under the Pennsylvania First Class City Home Rule Act. ~12,000 retail food licenses citywide (2024 baseline); 6-12 month routine inspection cadence. § 6-301 USDA jurisdictional carve-out at retail defines retail / wholesale interface for federal vs. local jurisdiction; particularly affects small carnicerías + small ethnic-market retail (XC-11).
Cited in: SD1 Food; SD2 Meat & Poultry.

Philadelphia Code Title 6 Chapter 6-700 (Tobacco Retailers).
Tobacco-retailer density cap + 500-foot school buffer + license-fee architecture (Phila. Code Ch. 6-700). Operates within PA Clean Indoor Air Act preemption envelope. Small tobacco retailer differential burden per XC-11.
Cited in: SD5 Tobacco.

Philadelphia Department of Public Health (PDPH) Office of Food Protection (OFP) at 1101 Market Street.
Retail food licensing + routine inspection + complaint-driven inspection. Administrative vulnerability MODERATE — local capacity stable; sub-area inspection density variation flagged F4-T2P2-SD1-2.
Cited in: SD1 Food; SD2 Meat & Poultry.

PDPH Get Healthy Philly + Healthy Corner Store Initiative + Food Bucks.
Service-provider anchor at retail-access intervention layer. Food Bucks doubles SNAP value at participating farmers markets — structural-actor operating against the corner-store unit-price premium.
Cited in: SD1 Food.

FDA Philadelphia District at Mellon Independence Center, 900 US Customhouse, 2nd & Chestnut, Philadelphia, PA 19106.
Federal field office operating across the D4 sub-domains (food; drugs; biologics & devices; cosmetics). Administrative vulnerability HIGH post-April 2025 FDA RIF per MC-07.
Cited in: multiple D4 sub-domains.

DEA Philadelphia Field Division.
Federal field office for controlled-substance enforcement, registration, and rescheduling implementation per MC-01.
Cited in: SD6 Controlled Substances.

Sources for ongoing monitoring

FDA primary sources: fda.gov — Center pages (CDER, CBER, CDRH, CTP); HFP/OII reorganization documentation; MoCRA implementation tracking; per-Center RIF status (MC-07).
USDA FSIS: fsis.usda.gov — Salmonella regulatory pathway; NRTE breaded stuffed chicken status (MC-03); January 2026 public meeting docket FSIS-2025-0179; FSIS Philadelphia District 60 staffing post-RIF.
USDA ERS: ers.usda.gov — Household Food Security report status (terminated September 20, 2025 per MC-08); replacement data infrastructure pending.
CMS IRA Drug Price Negotiation: cms.gov — Round 2 MFP announcements (MC-04); GENEROUS Model implementation.
DEA Diversion Control Division: deadiversion.usdoj.gov — Medical Marijuana Dispensary Registration Portal status; rescheduling docket (MC-01); broader-rescheduling hearing record June-July 2026.
PA Department of Drug and Alcohol Programs (DDAP): pa.gov/agencies/ddap — PA PDMP architecture; overdose response.
Philadelphia Department of Public Health: phila.gov/health — OFP retail food licensing; Healthy Corner Store Initiative; Food Bucks coverage; PDPH overdose surveillance.
AATCLC v. HHS: PACER N.D. Cal. — menthol withdrawal litigation status (MC-06).
ACIP charter and litigation: HHS acip.hhs.gov — post-March 16, 2026 ruling implementation; April 9, 2026 charter rewrite scope (MC-02).
Casgevy / Lyfgenia uptake: Vertex Pharmaceuticals; CRISPR Therapeutics; Genetix Biotherapeutics (formerly bluebird bio) earnings reports — quarterly cell-collection and infusion data (MC-05).

Cross-references to other domain Legal Text appendices

For the broader regulatory and policy environment within which the Food, Drug & Device instruments operate, see: